Asgard Therapeutics featured at the Nature Biopharm Dealermakers

Posted 4 November, 2022

Asgard Therapeutics was featured at the Nature Biopharma dealmakers new collection, highlighting companies developing innovative cell and gene therapies. Take a closer look at how Asgard’s in-vivo direct reprogramming approach can convert tumor cells into antigen-presenting dendritic cells and turn cold tumors hot.